NIVF: יתרות מזומנים למניה NewGenIvf Corp

NewGenIvf Group Limited is developing an Asian reproductive medicine ecosystem, fostering long-term patient loyalty. The cash per share history visualizes the business's financial stability, where 0.85 serves as the current parameter value. Revenues are based on IVF procedures and surrogacy in Southeast Asia. A stable effect is currently combined with the potential for future expansion of the center network.
פילוחים אנליטיים של חברת NewGenIvf Group Limited

NewGenIvf Group Limited demonstrates stable operational activity within the biopharmaceutical sector. This metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. It determines the business's real financial reserve, which is critical during supply chain disruptions or regulatory barriers. A high indicator guarantees the company's autonomy amidst geopolitical shocks. By analyzing cash-per-share trends, an investor assesses the balance between defensive liquidity and capital efficiency.